Pacs Group Stock Number Of Shares Shorted
| PACS Stock | 41.36 0.18 0.44% |
Fundamental analysis of PACS allows traders to better anticipate movements in PACS's stock price by examining its financial health and performance throughout various phases of its business cycle.
PACS | Number Of Shares Shorted | Build AI portfolio with PACS Stock |
PACS Group Company Number Of Shares Shorted Analysis
PACS's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current PACS Number Of Shares Shorted | 3.14 M |
Most of PACS's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PACS Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PACS Number Of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for PACS is extremely important. It helps to project a fair market value of PACS Stock properly, considering its historical fundamentals such as Number Of Shares Shorted. Since PACS's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PACS's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PACS's interrelated accounts and indicators.
Click cells to compare fundamentals
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, PACS Group has 3.14 M of outstending shares currently sold short by investors. This indicator is about the same for the Health Care Providers & Services average (which is currently at 3.2 M) sector and significantly higher than that of the Health Care industry. The number of shares shorted for all United States stocks is 33.33% higher than that of the company.
PACS Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PACS's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PACS could also be used in its relative valuation, which is a method of valuing PACS by comparing valuation metrics of similar companies.PACS is currently under evaluation in number of shares shorted category among its peers.
PACS ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PACS's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PACS's managers, analysts, and investors.Environmental | Governance | Social |
PACS Fundamentals
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.0007 % | ||||
| Current Valuation | 9.56 B | ||||
| Shares Outstanding | 155.18 M | ||||
| Shares Owned By Insiders | 72.28 % | ||||
| Shares Owned By Institutions | 28.69 % | ||||
| Number Of Shares Shorted | 3.14 M | ||||
| Price To Book | 7.40 X | ||||
| Price To Sales | 1.25 X | ||||
| Revenue | 4.09 B | ||||
| Gross Profit | 519.14 M | ||||
| EBITDA | 186.7 M | ||||
| Net Income | 55.76 M | ||||
| Total Debt | 3.5 B | ||||
| Book Value Per Share | 3.75 X | ||||
| Cash Flow From Operations | 367.34 M | ||||
| Short Ratio | 3.12 X | ||||
| Earnings Per Share | 0.61 X | ||||
| Price To Earnings To Growth | 1.32 X | ||||
| Target Price | 34.67 | ||||
| Number Of Employees | 45.68 K | ||||
| Market Capitalization | 2.24 B | ||||
| Total Asset | 5.24 B | ||||
| Retained Earnings | 118.04 M | ||||
| Working Capital | (40.17 M) | ||||
| Net Asset | 5.24 B |
About PACS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PACS Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PACS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PACS Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PACS Stock Analysis
When running PACS's price analysis, check to measure PACS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS is operating at the current time. Most of PACS's value examination focuses on studying past and present price action to predict the probability of PACS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS's price. Additionally, you may evaluate how the addition of PACS to your portfolios can decrease your overall portfolio volatility.